Tamsulosin and Tolterodine in the Treatment of Benign Prostatic Hyperplasia Patients with LUTS
Qinzhang Wang
Abstract
Qinzhang Wang
Abstract
Objective:To evaluate the clinical efficacy of alpha-1 adrenoceptor antagonist (Tamsulosin) and Tolterodine in the treatment of benign prostatic hyperplasia (BPH) patients with LUTS. Methods:Eighty BPH patients with LUTS were randomly divided into treatment group and control group of 40 patients each.The patients in treatment group use Tamsulosin(200mg/qd)+ Tolterodine(1mg/bid,and patients in control group only use tamsulosin(200mg/qd). Results:There was significantly difference between two groups (P 0. 01) after three weeks later. Conclusion:Treatment with Tamsulosin and Tolterodine was effective in raising the LUTS with BPH patients.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To evaluate the clinical efficacy of alpha-1 adrenoceptor antagonist (Tamsulosin) and Tolterodine in the treatment of benign prostatic hyperplasia (BPH) patients with LUTS. Methods:Eighty BPH patients with LUTS were randomly divided into treatment group and control group of 40 patients each.The patients in treatment group use Tamsulosin(200mg/qd)+ Tolterodine(1mg/bid,and patients in control group only use tamsulosin(200mg/qd). Results:There was significantly difference between two groups (P 0. 01) after three weeks later. Conclusion:Treatment with Tamsulosin and Tolterodine was effective in raising the LUTS with BPH patients.
Key concepts: Tolterodine, Tamsulosin, Urology, Medicine, Hyperplasia, Antagonist, Benign prostatic hyperplasia (BPH), Prostate